Armistice Capital’s InMed Pharmaceuticals INM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-13,348
Closed -$97.2K 321
2024
Q1
$97.2K Buy
13,348
+3,050
+30% +$22.4K ﹤0.01% 307
2023
Q4
$85.7K Buy
+10,298
New +$100K ﹤0.01% 259
2023
Q1
Sell
-4,858
Closed -$196K 241
2022
Q4
$196K Buy
4,858
+358
+8% +$24.1K 0.01% 155
2022
Q3
$593K Buy
4,500
+2,588
+135% +$479K 0.01% 147
2022
Q2
$450 Buy
+1,912
New +$731K 0.01% 138
2021
Q4
Sell
-1,020
Closed -$893K 159
2021
Q3
$893K Sell
1,020
-760
-43% -$906K 0.02% 123
2021
Q2
$2.83M Buy
1,780
+1,310
+279% +$2.03M 0.07% 102
2021
Q1
$776K Buy
+470
New +$1.01M 0.02% 104

Other funds holding INM